inflammation and glp-1 Therapies May Benefit MPN MDS Patients Beyond metabolic benefits: The underexplored

DiMarchis quote as follows: Many diseases share the same root causes, which is inhibition of AMPK activity leading to disruption of many metabolic pathways. GLP-1 drugs activate AMPK primarily through reducing calorie intake

many require PA Blue Cross Blue Shield Major 2026 coverage restrictions announced Cigna Often covers with step therapy requirements Anthem Blue Cross Separate policies from other BCBS affiliates Kaiser Permanente Regional variations

GLP-1s often work better for both goals

Your care team includes clinical support nurses, nurse practitioners, and board-certified obesity medicine physicians